| Symbol |
Name |
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL1
|
angiopoietin-like 1
|
|
ATP5A1
|
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
|
|
ATP7A
|
ATPase, Cu++ transporting, alpha polypeptide
|
|
AURKA
|
aurora kinase A
|
|
B2M
|
beta-2-microglobulin
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BPI
|
bactericidal/permeability-increasing protein
|
|
BPIFA2
|
BPI fold containing family A, member 2
|
|
BPIFB1
|
BPI fold containing family B, member 1
|
|
BSG
|
basigin (Ok blood group)
|
|
C8G
|
complement component 8, gamma polypeptide
|
|
CA2
|
carbonic anhydrase II
|
|
CA3
|
carbonic anhydrase III
|
|
CA9
|
carbonic anhydrase IX
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta)
|
|
CD109
|
CD109 molecule
|
|
CD14
|
CD14 molecule
|
|
CD1A
|
CD1a molecule
|
|
CD209
|
CD209 molecule
|
|
CD5
|
CD5 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CES1
|
carboxylesterase 1
|
|
CHRM2
|
cholinergic receptor, muscarinic 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSG
|
cathepsin G
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL6
|
chemokine (C-X-C motif) ligand 6
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CYGB
|
cytoglobin
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DHFR
|
dihydrofolate reductase
|
|
EGFR
|
epidermal growth factor receptor
|
|
ERAP1
|
endoplasmic reticulum aminopeptidase 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FKBP14
|
FK506 binding protein 14, 22 kDa
|
|
FKBP1A
|
FK506 binding protein 1A, 12kDa
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1
|
|
FOXM1
|
forkhead box M1
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GGCT
|
gamma-glutamylcyclotransferase
|
|
GLIPR1
|
GLI pathogenesis-related 1
|
|
GLRA1
|
glycine receptor, alpha 1
|
|
GSN
|
gelsolin
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HAS2
|
hyaluronan synthase 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HOXA9
|
homeobox A9
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSD3B2
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2
|
|
IFNG
|
interferon, gamma
|
|
IL16
|
interleukin 16
|
|
IL18
|
interleukin 18
|
|
IL6
|
interleukin 6
|
|
JAG1
|
jagged 1
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KL
|
klotho
|
|
KLF3
|
Kruppel-like factor 3 (basic)
|
|
LCN1
|
lipocalin 1
|
|
LEP
|
leptin
|
|
LIF
|
leukemia inhibitory factor
|
|
LVRN
|
laeverin
|
|
MAOB
|
monoamine oxidase B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR218-1
|
microRNA 218-1
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MPO
|
myeloperoxidase
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
NAGPA
|
N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
|
|
NBN
|
nibrin
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NEIL2
|
nei endonuclease VIII-like 2 (E. coli)
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NID2
|
nidogen 2 (osteonidogen)
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOTCH3
|
notch 3
|
|
NTF3
|
neurotrophin 3
|
|
NUTM1
|
NUT midline carcinoma, family member 1
|
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II
|
|
PDCD5
|
programmed cell death 5
|
|
PF4
|
platelet factor 4
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PMP2
|
peripheral myelin protein 2
|
|
PNLIP
|
pancreatic lipase
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRL
|
prolactin
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PXN
|
paxillin
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RLBP1
|
retinaldehyde binding protein 1
|
|
S100A7
|
S100 calcium binding protein A7
|
|
SAA1
|
serum amyloid A1
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SEC14L2
|
SEC14-like 2 (S. cerevisiae)
|
|
SERPINB4
|
serpin peptidase inhibitor, clade B (ovalbumin), member 4
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC25A32
|
solute carrier family 25 (mitochondrial folate carrier), member 32
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TLR1
|
toll-like receptor 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR6
|
toll-like receptor 6
|
|
TMPRSS11B
|
transmembrane protease, serine 11B
|
|
TMPRSS11E
|
transmembrane protease, serine 11E
|
|
TMSB10
|
thymosin beta 10
|
|
TMSB4X
|
thymosin beta 4, X-linked
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VTN
|
vitronectin
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|